MStranslate

24/06/2026

Registration for Patient Community Day is now open! Be among the first to learn about the latest advances in multiple sclerosis research, straight from the people shaping and presenting the science at the world's largest MS research conference. You can register for free to join us in Toronto or online via the link below.

https://www.ectrimspatientcommunity.eu/registration

22/06/2026

If you missed the recent webinar on mental health and multiple sclerosis, the full replay is now available on the Multiple Sclerosis Auckland website. In the discussion, Brett talks with Dr Rebecca Maguire (a research psychologist and person living with MS) about stigma, uncertainty, anxiety and the best ways to have open conversations and manage the psychological aspects of MS on a daily basis.

Living with Multiple Sclerosis isn’t just about managing physical symptoms—it’s about looking after your mind and spirit, too.

18/06/2026

With this week being World Continence Week, MS Australia have shared some suggestions from their Lived Experience Expert Panel about the best ways to manage this common, but often not talked about, symptom of multiple sclerosis.

Living with MS and incontinence can be challenging, but it is also manageable with the right support, planning and practical strategies. We asked MS Australia’s Lived Experience Expert Panel (LEEP) about the ups and downs, and their top tips for managing this invisible symptom of MS.

15/06/2026

Following on from our post yesterday about the potential for CAR T-cell therapy in multiple sclerosis, it is encouraging to see the positive initial results being achieved in other autoimmune diseases. A trial at UCL and UCLH - University College London Hospitals NHS Foundation Trust has found that a small number of people living with lupus have seen early improvements after receiving this treatment. There is still a lot of work to be done in this area, but we will continue to provide updates as they become available.

Doctors say therapy that genetically modifies person’s T-cells could offer cure for chronic autoimmune disease

13/06/2026

Have you heard of CAR T-cell therapy? It is a treatment that reprograms a person's own immune cells to target specific cells in the body. In multiple sclerosis, researchers are exploring whether CAR T-cells could remove the immune cells that mistakenly attack the brain and spinal cord, potentially "resetting" the immune system and reducing disease activity.

Note: Image created using AI

12/06/2026

Firstly, even with the qualifier "looks like", the headline should avoid using the word "cure". Putting that aside, the article highlights growing evidence that HSCT can be a highly effective treatment for some people living with multiple sclerosis, with benefits that may be sustained over the long term. As the safety profile of HSCT has improved significantly over recent years, it is increasingly important to consider which individuals may benefit most from this approach and at what stage of their disease it should be offered as a treatment option.

Autologous hematopoietic stem cell transplant at experienced centers in the current era can include indefinite disease control with low relative risk, a new update suggests.

10/06/2026

Research simply cannot move forward without the people who choose to take part in it. A new ECTRIMS blog article featuring George from Shift.ms and Helena from Multiple Sclerosis Trust explores the benefits that people living with multiple sclerosis can gain from participating in research, as well as the motivations that inspire them to get involved.

For Helena Jidborg and George Pepper, getting involved in MS research began with personal questions about treatment and the future. Over time, they have grown to see it as a way to build hope, shape better care, and ensure everyone living with MS has a voice. Their own journeys reflect that of the w...

09/06/2026

VOTE NOW: The healthcare professional I spend the most time communicating with about my multiple sclerosis is my:

• neurologist (react with LIKE)
• my nurse (react with LOVE)
• my general practitioner, GP (react with WOW)
• another allied health professional (react with CARE)

03/06/2026

Most people have now heard about the link between Epstein–Barr virus (EBV) and multiple sclerosis (MS). But what do we actually know about how EBV may trigger MS, whether it can be targeted as a novel treatment approach, and if it could one day help us prevent MS altogether? Brett discusses these topics with Gavin Giovannoni and Tomas Olsson on the latest episode of the ECTRIMS (European Committee for Treatment & Research in Multiple Sclerosis) podcast.

Epstein–Barr virus (EBV) has become one of the most intensely studied topics in multiple sclerosis research. But how strong is the evidence linking EBV to MS, and could targeting the virus change the future of treatment and prevention? In this episode of the ECTRIMS Podcast, host Brett Drummond sp...

02/06/2026

A new study has found that many more people with multiple sclerosis reported problems with thinking, memory and concentration than showed measurable impairment on cognitive tests. One explanation for this difference is that other symptoms, such as depression or anxiety, affect perceived cognitive function. However, it may also indicate that current testing methods are not sensitive enough to detect the subtle changes that people living with MS notice in everyday life.